UK based company BioClad will be launching the BioPod IPS Unit which is the world’s first antimicrobial modular IPS unit to contain BioCote technology that is easy to install and arrives as a pre-plumbed and hygienically sealed unit.
BioClad will be exhibiting in Hall 16 on Stand G04-5 at Medica the world’s leading healthcare exhibition, to launch their latest BioPod IPS Unit and showcasing the BioArmis System and BioClad PVC Wall Cladding system.
BioCote uses silver ion technology which is proven to be effective in protection against all common microbes, including bacteria, mould and fungi. BioCote has been tested in real life environments, and is the only antimicrobial technology certified by world renowned product certification scheme HACCP International.
At Medica the company is actively looking to meet and engage with hospital owners, designers and medical firms - that are involved with new build hospitals or refurbishments globally to enhance the benefits of BioClad wall and IPS systems.
Andy Newbould, BioClad’s Sales Director said: “As a company we are excited to be launching the world’s first antimicrobial modular IPS unit containing BioCote technology, at the world’s leading healthcare exhibition - alongside raising awareness and interest around how our products are ideal for new build hospitals and refurbishments.”
If you would like to arrange an interview with BioClad during Medica 2016, please contact:
Jason Brannan, PR & Communications Director at Medilink Yorkshire and Humber
Tel: 0114 232 9292 Email: email@example.com